The formulas
Swipe to compare. Open a formula for sourcing, safety, and development context.
Swipe, use arrow keys, or select a formula.
A scheduled evening routine followed by one brief morning record.
Prototype formula in development
Prototype amounts · under review
R&D prototype—not final Supplement Facts or consumer dosing instructions. Final ingredient forms, safety, stability, testing, and claims remain under review.
120mg
elemental magnesiumIngredient standardFully reacted, unbuffered chelate with declared elemental yield, dissolution, and potency testing.
Why it’s being testedA feasibility-first prototype amount; the exact combined formula still requires validation.
Full prototype amount: 120 mg elemental magnesium
300mg
evening prototypeIngredient standardRoot-only named extract with a withanolide specification, identity testing, and liver-risk review.
Why it’s being testedPrototype amount for the evening architecture—not an established finished-product effect.
Full prototype amount: 300 mg in the evening prototype
Tart cherry and token free glycine are outside V1. Capsule count remains a manufacturing feasibility question until bulk-density and fill testing. Ashwagandha warnings and interactions still require clinician and regulatory review.
Protocol role
One clear scheduled action, then a separate morning check-in—without collapsing the two into a score.
App record
Sleep duration, bedtime and wake consistency, and feeling rested lead; wearable stages remain context, not a promise.
Personal reference
A 7–14 day pre-product record creates the reference. Starting immediately is labeled calibration, not baseline.
Availability
The first pilot focuses on one protocol so the record remains interpretable.
02 / 03